Search Results - "Gaetani, Silvana"
-
1
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
Published in Frontiers in neuroscience (02-02-2017)“…As a consequence of an increasingly aging population, the number of people affected by neurodegenerative disorders, such as Alzheimer's disease, Parkinson's…”
Get full text
Journal Article -
2
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder
Published in Neuropsychopharmacology (New York, N.Y.) (01-10-2020)“…Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapies show poor response rates and safety concerns, thus…”
Get full text
Journal Article -
3
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery
Published in International journal of pharmaceutics (31-10-2011)“…The aim of this study was to characterize nanoparticles (NPs) composed of chitosan (CS) and evaluate their potential for brain delivery of the neurotransmitter…”
Get full text
Journal Article -
4
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Published in Molecular neurobiology (01-04-2019)“…Impairment of biliverdin reductase-A (BVR-A) is an early event leading to brain insulin resistance in AD. Intranasal insulin (INI) administration is under…”
Get full text
Journal Article -
5
Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review
Published in Nutrients (01-09-2022)“…Alzheimer's disease (AD) is a progressive degenerative disorder of the central nervous system, characterized by neuroinflammation, neurotransmitter deficits,…”
Get full text
Journal Article -
6
The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease
Published in Journal of Alzheimer's disease (01-01-2015)“…Alzheimer's disease (AD) is the most common form of progressive neurodegenerative disease characterized by cognitive impairment and mental disorders. The…”
Get more information
Journal Article -
7
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
Published in Translational psychiatry (31-01-2018)“…In an aging society, Alzheimer’s disease (AD) exerts an increasingly serious health and economic burden. Current treatments provide inadequate symptomatic…”
Get full text
Journal Article -
8
Editorial: Alzheimer's Disease: Original Mechanisms and Translational Impact
Published in Frontiers in pharmacology (26-02-2020)Get full text
Journal Article -
9
Glutamate and Mitochondria: Two Prominent Players in the Oxidative Stress-Induced Neurodegeneration
Published in Current Alzheimer research (01-02-2016)“…The aetiology of major neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD) is still unknown, but increasing evidences…”
Get more information
Journal Article -
10
Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake
Published in Proceedings of the National Academy of Sciences - PNAS (05-08-2014)“…Key factors driving eating behavior are hunger and satiety, which are controlled by a complex interplay of central neurotransmitter systems and peripheral…”
Get full text
Journal Article -
11
From Autism to Eating Disorders and More: The Role of Oxytocin in Neuropsychiatric Disorders
Published in Frontiers in neuroscience (12-01-2016)“…Oxytocin (oxy) is a pituitary neuropeptide hormone synthesized from the paraventricular and supraoptic nuclei within the hypothalamus. Like other…”
Get full text
Journal Article -
12
PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer's Disease
Published in International journal of molecular sciences (03-02-2023)“…In the present study, we used a mouse model of Alzheimer's disease (AD) (3×Tg-AD mice) to longitudinally analyse the expression level of PDIA3, a protein…”
Get full text
Journal Article -
13
Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task
Published in Frontiers in pharmacology (27-09-2019)“…Besides the memory impairment, Alzheimer’s disease (AD) is often complicated by neuropsychiatric symptoms also known as behavioral and psychological symptoms…”
Get full text
Journal Article -
14
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease
Published in Biochimica et biophysica acta. Molecular basis of disease (01-10-2018)“…PET scan analysis demonstrated the early reduction of cerebral glucose metabolism in Alzheimer disease (AD) patients that can make neurons vulnerable to damage…”
Get full text
Journal Article -
15
Food Intake Regulates Oleoylethanolamide Formation and Degradation in the Proximal Small Intestine
Published in The Journal of biological chemistry (12-01-2007)“…Oleoylethanolamide (OEA) is a lipid mediator that inhibits food intake by activating the nuclear receptor peroxisome proliferator-activated receptor-α. In the…”
Get full text
Journal Article -
16
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer's Disease
Published in Journal of Alzheimer's disease (01-01-2017)“…A disruption to circadian rhythmicity and the sleep/wake cycle constitutes a major feature of Alzheimer's disease (AD). The maintenance of circadian…”
Get more information
Journal Article -
17
The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease
Published in Current Alzheimer research (01-02-2016)“…The human brain is the most cholesterol-rich organ harboring 25% of the total cholesterol pool of the whole body. Cholesterol present in the central nervous…”
Get more information
Journal Article -
18
Regulation of adenosine A2A receptor gene expression in a model of binge eating in the amygdaloid complex of female rats
Published in Journal of psychopharmacology (Oxford) (01-12-2019)“…Background: Pharmacological treatment approaches for eating disorders, such as binge eating disorder and bulimia nervosa, are currently limited. Methods and…”
Get full text
Journal Article -
19
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease
Published in Neurobiology of aging (01-06-2012)“…Abstract Deficits in glutamate neurotransmission and mitochondrial functions were detected in the frontal cortex (FC) and hippopcampus (HIPP) of aged…”
Get full text
Journal Article -
20
Modulation of the Oxidative Stress and Lipid Peroxidation by Endocannabinoids and Their Lipid Analogues
Published in Antioxidants (18-07-2018)“…Growing evidence supports the pivotal role played by oxidative stress in tissue injury development, thus resulting in several pathologies including…”
Get full text
Journal Article